InsiderTrades.com logo

CNTX Insider Trading

Insider Ownership Percentage: 2.80%
Insider Buying (Last 12 Months): $107,206.40
Insider Selling (Last 12 Months): $0.00

Context Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Context Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Context Therapeutics Share Price & Price History

Current Price: $0.62
Price Change: ▼ Price Decrease of -0.0296 (-4.54%)
As of 06/13/2025 02:02 PM ET

This chart shows the closing price history over time for CNTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Context Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2025Martin A. LehrCEOBuy100,000$0.70$70,000.00920,190View SEC Filing Icon  
6/6/2025Alex C. LevitInsiderBuy20,000$0.58$11,600.0029,000View SEC Filing Icon  
6/6/2025Jennifer Lynn Minai-AzaryCFOBuy40,010$0.64$25,606.4080,010View SEC Filing Icon  
2/21/2023Martin A. LehrCEOBuy5,823$0.84$4,891.32159,701View SEC Filing Icon  
2/13/2023Martin A. LehrCEOBuy5,606$0.87$4,877.22153,878View SEC Filing Icon  
2/6/2023Martin A. LehrCEOBuy5,040$0.97$4,888.80148,272View SEC Filing Icon  
1/30/2023Martin A. LehrCEOBuy7,027$0.70$4,918.90143,232View SEC Filing Icon  
1/23/2023Martin A. LehrCEOBuy6,839$0.72$4,924.08136,205View SEC Filing Icon  
1/17/2023Martin A. LehrCEOBuy6,783$0.74$5,019.42129,366View SEC Filing Icon  
12/16/2022Jennifer Lynn Minai-AzaryCFOBuy25,000$0.74$18,500.0040,000View SEC Filing Icon  
12/9/2022Alex C. LevitInsiderBuy6,000$0.85$5,100.009,000View SEC Filing Icon  
8/19/2022Martin A. LehrCEOBuy13,000$1.85$24,050.00102,583View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Context Therapeutics (NASDAQ:CNTX)

14.03% of Context Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CNTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Context Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2025Ally Bridge Group NY LLC1,157,448$0.71M0.6%-26.6%1.290%Search for SEC Filing on Google Icon
5/15/2025Landscape Capital Management L.L.C.41,216$25K0.0%-54.2%0.046%Search for SEC Filing on Google Icon
5/14/2025Affinity Asset Advisors LLC660,589$0.40M0.0%-34.9%0.736%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP90,000$94K0.1%-93.0%0.120%Search for SEC Filing on Google Icon
2/17/2025Shay Capital LLC50,000$52K0.0%N/A0.067%Search for SEC Filing on Google Icon
2/17/2025MPM Bioimpact LLC14,705,882$15.44M2.2%N/A19.608%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC178,718$0.19M0.0%+24.2%0.238%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC29,900$31K0.0%N/A0.040%Search for SEC Filing on Google Icon
2/17/2025Allostery Investments LP950,166$1M1.0%N/A1.267%Search for SEC Filing on Google Icon
2/17/2025Ally Bridge Group NY LLC1,576,762$1.66M1.4%-10.3%2.102%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC27,395$29K0.0%N/A0.037%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp113,565$0.12M0.0%-34.2%0.151%Search for SEC Filing on Google Icon
2/14/2025Blue Owl Capital Holdings LP6,357,928$6.68M1.6%+17.5%8.477%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP203,286$0.21M0.0%N/A0.271%Search for SEC Filing on Google Icon
2/13/2025Affinity Asset Advisors LLC1,015,340$1.07M0.1%-23.1%1.354%Search for SEC Filing on Google Icon
2/13/2025Walleye Capital LLC166,306$0.18M0.0%+51.7%0.222%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC338,435$0.36M0.0%+412.8%0.451%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC351,094$0.37M0.1%-6.1%0.468%Search for SEC Filing on Google Icon
2/12/2025Landscape Capital Management L.L.C.90,000$94K0.0%N/A0.120%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC628,729$0.66M0.0%+9.2%0.838%Search for SEC Filing on Google Icon
2/12/2025Franklin Resources Inc.4,003,380$4.20M0.0%+115.9%5.338%Search for SEC Filing on Google Icon
1/17/2025Clear Harbor Asset Management LLC57,804$61K0.0%+60.6%0.077%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.1,853,988$3.69M0.0%N/A2.472%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC575,899$1.13M0.0%-6.8%0.768%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd45,635$89K0.0%N/A0.061%Search for SEC Filing on Google Icon
11/15/2024State Street Corp111,907$0.22M0.0%+21.5%0.149%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC1,757,524$3.45M1.8%-6.8%2.343%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC6,934,982$13.59M4.0%-6.5%9.247%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC1,935,484$3.88M0.2%N/A2.581%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC2,258,065$4.53M0.0%N/A3.011%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP5,161,290$10.35M2.9%N/A6.882%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC1,619,140$3.25M0.4%+392.4%2.159%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC7,419,355$14.88M2.8%N/A9.893%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC1,886,232$3.78M2.3%+159.8%2.515%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC65,200$0.13M0.0%+63.4%0.087%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.1,108,357$1.53M0.3%+13.7%1.478%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.975,000$1.10M0.3%N/A6.107%Search for SEC Filing on Google Icon
11/15/2023Affinity Asset Advisors LLC328,817$0.50M0.1%+22.9%2.059%Search for SEC Filing on Google Icon
8/21/2023Affinity Asset Advisors LLC267,574$0.43M0.1%N/A1.675%Search for SEC Filing on Google Icon
7/21/2023Clear Harbor Asset Management LLC36,000$58K0.0%N/A0.225%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC1,143,745$0.75M0.2%-11.5%7.162%Search for SEC Filing on Google Icon
2/14/2023swisspartners Ltd.180,000$0.12M0.2%+111.8%1.127%Search for SEC Filing on Google Icon
11/14/2022Worth Venture Partners LLC322,628$0.36M0.2%+8.4%2.021%Search for SEC Filing on Google Icon
11/1/2022swisspartners Ltd.85,000$94K0.1%+101.3%0.532%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC46,445$98K0.0%N/A0.291%Search for SEC Filing on Google Icon
8/12/2022Affinity Asset Advisors LLC883,654$1.87M0.8%+13.6%5.535%Search for SEC Filing on Google Icon
5/4/2022swisspartners Ltd.14,315$4.98M3.5%-66.1%0.090%Search for SEC Filing on Google Icon
2/14/2022Altium Capital Management LP493,531$1.31M0.4%N/A4.501%Search for SEC Filing on Google Icon
2/11/2022QCM Cayman Ltd.14,041$37K0.2%N/A0.128%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC762,721$2.03M0.6%N/A6.955%Search for SEC Filing on Google Icon
2/9/2022swisspartners Ltd.42,235$0.11M0.1%N/A0.385%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Context Therapeutics logo
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Read More on Context Therapeutics

Today's Range

Now: $0.62
Low: $0.61
High: $0.63

50 Day Range

MA: $0.75
Low: $0.55
High: $1.00

52 Week Range

Now: $0.62
Low: $0.49
High: $2.75

Volume

104,172 shs

Average Volume

301,537 shs

Market Capitalization

$55.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Context Therapeutics?

Context Therapeutics' top insider shareholders include:
  1. Martin A Lehr (CEO)
  2. Jennifer Lynn Minai-Azary (CFO)
  3. Alex C Levit (Insider)
Learn More about top insider investors at Context Therapeutics.

Who are the major institutional investors of Context Therapeutics?

Context Therapeutics' top institutional shareholders include:
  1. Ally Bridge Group NY LLC — 1.29%
  2. Affinity Asset Advisors LLC — 0.74%
  3. Landscape Capital Management L.L.C. — 0.05%
Learn More about top institutional investors of Context Therapeutics stock.

Which major investors are selling Context Therapeutics stock?

In the last quarter, CNTX stock was sold by these institutional investors:
  1. Ally Bridge Group NY LLC
  2. Affinity Asset Advisors LLC
  3. Landscape Capital Management L.L.C.